284 related articles for article (PubMed ID: 10478608)
1. New perspectives for asthma treatment: anti-leukotriene drugs.
García-Marcos L; Schuster A
Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
[TBL] [Abstract][Full Text] [Related]
2. Antileukotrienes in asthma: present situation.
García-Marcos L; Schuster A
Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
4. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
5. Use of leukotriene antagonists in childhood asthma.
Krawiec ME; Wenzel SE
Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
[TBL] [Abstract][Full Text] [Related]
6. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.
Warner JO
Allergy; 2001; 56 Suppl 66():22-9. PubMed ID: 11421938
[TBL] [Abstract][Full Text] [Related]
7. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
9. [The anti-leukotrienes: their use in asthma].
Devillier P; Millart H; Advenier C
Rev Med Brux; 1997 Sep; 18(4):279-85. PubMed ID: 9411661
[TBL] [Abstract][Full Text] [Related]
10. Benefit-risk assessment of antileukotrienes in the management of asthma.
García-Marcos L; Schuster A; Pérez-Yarza EG
Drug Saf; 2003; 26(7):483-518. PubMed ID: 12735786
[TBL] [Abstract][Full Text] [Related]
11. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
Dunn CJ; Goa KL
Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
[TBL] [Abstract][Full Text] [Related]
12. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
13. Pranlukast: a review of its use in the management of asthma.
Keam SJ; Lyseng-Williamson KA; Goa KL
Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
[TBL] [Abstract][Full Text] [Related]
14. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
Adkins JC; Brogden RN
Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
[TBL] [Abstract][Full Text] [Related]
15. Antileukotrienes in upper airway inflammatory diseases.
Cingi C; Muluk NB; Ipci K; Şahin E
Curr Allergy Asthma Rep; 2015 Nov; 15(11):64. PubMed ID: 26385352
[TBL] [Abstract][Full Text] [Related]
16. The role of antileukotrienes in asthma management.
Tan RA
Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
18. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
19. A review on leukotrienes and their receptors with reference to asthma.
Singh RK; Tandon R; Dastidar SG; Ray A
J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
